Crossbow Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Crossbow Therapeutics's estimated annual revenue is currently $5.9M per year.
- Crossbow Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Crossbow Therapeutics has 38 Employees.
- Crossbow Therapeutics grew their employee count by 81% last year.
Crossbow Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Crossbow Therapeutics?
Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.
keywords:N/A
N/A
Total Funding
38
Number of Employees
$5.9M
Revenue (est)
81%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4M | 38 | 0% | $10M |
#2 | $5.5M | 38 | -7% | N/A |
#3 | $4.4M | 38 | N/A | N/A |
#4 | $7.5M | 38 | 0% | N/A |
#5 | $4.4M | 38 | 46% | N/A |